ICON  Overview
ICON  Mission and Vision
ICON  NoroBio Standard
ICON  Our Culture/Values
ICON  Drug Registration
ICON  Marketing & promotion
ICON  GO & NGO Tender
ICON Finished Medicine
ICON Medical Products
ICON Food supplement
ICON Excipient
ICON Packing Material
ICON  Meet us in CPHI
Betterway
English |  Français  |   Email
SWITCH TO VETERINARY
Home > Products > Finished Medicine > Powder for injection
   - Finished Medicine
  - Tablets & Capsules
  - Powder for injection
  - Others
  - Injections
  - Bio Products
   + Medical Products
   + Food supplement
   + Excipient
   + Packing Material
 
 
 benzathine benzylpenicillin (2.4mega powder for injection)  
 
Indications
Early syphilis, late syphilis or syphilis of unknown duration
Congenital syphilis (absence of clinical signs in the neonate and adequate treatment in the mother)
Endemic treponematoses (yaws, bejel, pinta)
Streptococcal tonsillitis
Prophylaxis of diphtheria in the event of direct contact
Primary and secondary prophylaxis of rheumatic fever
 
Forms and strengths, route of administration
Powder for injection in vials of:
2.4 MIU (1.8 g), to be dissolved in 8 ml of water for injection, for IM injectionNEVER FOR IV INJECTION NOR INFUSION
 
Dosage
SyphilisChild: 50 000 IU (37.5 mg)/kg per injection (max. 2.4 MIU or 1.8 g per injection)Adult: 2.4 MIU (1.8 g) per injection
Yaws, bejel, pintaChild under 10 years: 1.2 MIU (900 mg) per injectionChild 10 years and over and adult: 2.4 MIU (1.8 g) per injection
Streptococcal tonsillitis, prophylaxis of diphtheria, prophylaxis of rheumatic feverChild under 30 kg: 600 000 IU (450 mg) per injectionChild 30 kg and over and adult: 1.2 IU (900 mg) per injection
 
Contra-indications, adverse effects, precautions
Do not administer to penicillin-allergic patients.Administer with caution to patients allergic to cephalosporins (cross-sensitivity may occur) and renal impairment (reduce dosage).May cause:
gastroinstestinal disturbances, pain at injection site, allergic reactions sometimes severe;
Jarisch-Herxheimer reaction (fever, chills, myalgia, tachycardia) in patients with syphilis;
convulsions in the event of high dosages or renal impairment;
symptoms of shock with neuropsychiatric disorders if accidentally injected intravascularly.
Ensure that the IM injection does not enter a blood vessel.
Do not combine with methotrexate.
Pregnancy: no contra-indication
Breast-feeding: no contra-indication
© 2010 Noro Bio-Pharmaceutical Co., Ltd. all rights reservedExport Company